USE OF SODIUM-HYDROGEN-EXCHANGE-INHIBITORS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE CARDIOTOXIC EFFECT OF SOME SUBSTANCES

摘要

of a cytostatic agent and a Na+/H+ exchange inhibitor during cancer therapy reduces the cytostatic's cardiotoxicity, allowing it to be administered in higher doses. - The use of a Na+/H+ exchange inhibitor is claimed for reducing the cardiotoxicity of certain drugs.